Nurix Therapeutics
Nurix Therapeutics founded in 2009 and headquartered in San Francisco, California, develops therapies that control disease-causing proteins and develops drugs as treatments for hematologic cancers and immune-mediated diseases including immuno-oncology therapeutics for cancer.
Last updated on
About Nurix Therapeutics
Founded
2009Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$354MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
San FranciscoState
CaliforniaCountry
United StatesTech Stack (77)
